Candel Therapeutics Shares Are Trading Higher After the Company Received FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
在Candel Therapeutics獲得美國食品藥品管理局用於治療胰腺癌的 CAN-2409 孤兒藥認定後,該公司股價走高
Candel Therapeutics Shares Are Trading Higher After the Company Received FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
在Candel Therapeutics獲得美國食品藥品管理局用於治療胰腺癌的 CAN-2409 孤兒藥認定後,該公司股價走高
使用瀏覽器的分享功能,分享給你的好友吧